HERG Screening Companies
HERG, which stands for the human ether-a-go-go-related gene, is a gene that encodes a potassium ion channel in the heart. Testing or screening for HERG is often related to assessing the potential proarrhythmic effects of drugs, as disruptions in the HERG channel can lead to cardiac arrhythmias, specifically a type known as Torsades de Pointes. Companies involved in HERG screening typically offer services and technologies to assess a drug's impact on HERG channels. These screenings are essential in the drug development process to ensure the safety of new pharmaceuticals.